Bergen, Norway 16.09.21
Today the Board of Directors (the "Board") of Lifecare AS (the "Company" or"Lifecare") has passed a resolution to convene an Extraordinary General Meeting("EGM") on 30 September 2021 to approve a revocation of a board authorizationfor a share capital increase of up to NOK 3.238.093 of the Company's sharecapital passed by the Company's EGM on 30 July 2020. The resolution is part ofthe process towards the planned capital increase previously announced.
Notice of the EGM is enclosed to this announcement.
To save the environment and reduce costs incurred sending the notification bypost to the shareholders, please see attached a manual (in Norwegian) on how toreceive notices and information electronically instead of by post.
This is LifecareLifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth Oslo (LIFE).
Further informationJoacim Holter, CEO, Lifecare AS, email@example.com, +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Kine Hereid, Investor Relations at Lifecare AS, on 16.09.2021 at16:30 CET.